Monthly Archives: October 2012

Protease inhibitors. Part 2

Posted on October 11, 2012 by Fred Smith

Several phase II and III studies have assessed the efficacy and safety of telaprevir in treatment naive G1 patients, concluding that triple therapy yields a higher rate of SVR than current SoC and lower rates of relapse. The SVR for … Continue reading →

Posted in Other | Leave a comment